MedTrace Logo

Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI

NCT06229444 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17043

Last updated 2024-09-19

No results posted yet for this study

Summary

The goal of this prospective, digital randomized controlled trial is to evaluate the effectiveness of a predictive ILI detection algorithm and associated alerts during influenza season for adults living in the contigent United States. The main study objectives are to assess the effectiveness of predictive ILI detection algorithm and associated alerts on protective behaviors related to ILI and assess the accuracy of a predictive ILI detection algorithm using participant self-reported ILI symptoms and diagnosis.

Conditions

Interventions

BEHAVIORAL

ILI Predictive Alerts, Reactive Content, and Proactive Content

Participants receive ILI-related education, feedback, and opportunities to self-monitor ILI symptoms, in addition they also receive alerts about potential ILI illness, and reactive and personalized content about protective health behaviors.

BEHAVIORAL

ILI Predictive Alerts, Reactive Content

Participants receive alerts about potential ILI illness, and reactive and personalized content about protective health behaviors.

BEHAVIORAL

Proactive Content

Participants receive ILI-related education, feedback, and opportunities to self-monitor ILI symptoms.

BEHAVIORAL

No Intervention

Participants will not receive predictive alerts or reactive content after reporting symptoms or proactive IILI-related health educational content

Sponsors & Collaborators

Principal Investigators

  • Ernesto H.N. Ramirez, PhD · Evidation

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-12
Primary Completion
2024-08-05
Completion
2024-09-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06229444 on ClinicalTrials.gov